Athens News Matters: UGA study reports many of the COVID-19 drug trials early in the pandemic not representative

It’s been almost three years since COVID-19 erupted all over the globe, and a new research study from the University of Georgia finds that many of the COVID-19 drug trials conducted early in the pandemic were not representative of those most affected by the virus, and inconsistently reported certain demographic characteristics, such as the race and ethnicity of participants. Alexia Ridley discusses the study with one of its authors, Dr. Sharmon Osae, assistant clinical professor at UGA’s College of Pharmacy